TMAB Houston Headquarters
Texas Medical Center Innovation
2450 Holcombe Blvd
Houston, Texas 77021
TMAB is on a mission to develop the world’s best and first-in-class radiopharmaceuticals targeting advanced neuroendocrine cancers.
TMAB is on a mission to develop best and first-in-class monoclonal antibodies for overcoming anti-VEGF treatment resistance in ovarian, endometrial, brain and colorectal cancers.
Get in touch
All Rights Reserved, TMAB Therapeutics, Inc. © 2024